tirzepatide simply adds a second pathway (GIP)
Intramuscular (IM) : Common sites include the upper arm (deltoid muscle), thigh (vastus lateralis), or buttocks (gluteus medius)
Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ: Homocysteine metabolism in children with Down syndrome: in vitro modulation
Retatrutide adds a third mechanism, glucagon receptor activation, and in Phase 3 trials has demonstrated approximately 28% average body weight reduction over 18 months, compared to tirzepatides 22.5% in its own Phase 3 programme [1][2]
Pour un bon apport, il est conseill de consommer des fruits et lgumes au quotidien en favorisant : les asperges
injecting slowly rather than quickly gives tissues time to adjust and can decrease pain sensation